I disagree - IMO it is a big deal as it signals a shift in focus from product development (the product being BOT) to sales - in other words now there is a company, now there are four potential products, so now the focus is on selling BOT!
My hopes:
Trial momentum will be maintained.
Posited "problem" of BTX 1503 repair inhibition will be addressed.
Fast-tracking BTX 1801 to a product will be attempted.
Melanoma only studied if resources not diverted from existing work.
Funding from big pharma without cramping Botanix' style (or worth ).
- Forums
- ASX - By Stock
- BOT
- Ann: Appointment of Executive Director Dr Michael Thurn
Ann: Appointment of Executive Director Dr Michael Thurn, page-6
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.3¢ |
Change
-0.008(1.97%) |
Mkt cap ! $684.7M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $1.697M | 4.526M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 412726 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 368660 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 411276 | 0.370 |
21 | 259423 | 0.365 |
18 | 411062 | 0.360 |
9 | 279478 | 0.355 |
32 | 1193135 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 367618 | 23 |
0.380 | 280122 | 16 |
0.385 | 258031 | 6 |
0.390 | 10960 | 1 |
0.395 | 122143 | 2 |
Last trade - 14.53pm 04/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |